Document is current
Any future updates will be listed below
-
Authors
Corrà, Samantha
Zuppardo, Alessandro https://orcid.org/0000-0001-9601-3567
Valenzuela, Sebastian https://orcid.org/0000-0001-5153-8431
Jenninger, Louise
Cerutti, Raffaele
Sillamaa, Sirelin https://orcid.org/0000-0001-8077-9963
Hoberg, Emily
Johansson, Katarina A. S. https://orcid.org/0009-0005-8992-7631
Rovsnik, Urska
Volta, Sara
Silva-Pinheiro, Pedro https://orcid.org/0000-0002-0872-5749
Davis, Hannah
Trifunovic, Aleksandra https://orcid.org/0000-0002-5472-3517
Minczuk, Michal https://orcid.org/0000-0001-8242-1420
Gustafsson, Claes M. https://orcid.org/0000-0003-3531-8468
Suomalainen, Anu https://orcid.org/0000-0003-4833-5195
Zeviani, Massimo
Macao, Bertil https://orcid.org/0000-0001-6511-6125
Zhu, Xuefeng https://orcid.org/0000-0002-4759-4446
Falkenberg, Maria https://orcid.org/0000-0001-8713-173X
Viscomi, Carlo https://orcid.org/0000-0001-6050-0566
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 14 May 2025
First Online: 23 May 2025
Competing interests
: M.F., C.M.G. and M.M. are co-founders. M.F., C.M.G., B.M., and X.Z. are shareholders of Pretzel Therapeutics and have received consulting fees. S.V. has received consulting fees from Pretzel therapeutics. The other authors do not have COI to disclose.
